Audio portion of audiovisual/broadcast material need not include established name
Rule
FDA does not intend to object if the established name is omitted from the audio (spoken) portion of audiovisual promotional labeling or broadcast advertisements. This rule uses 'broadcast' to mean all audiovisual promotional labeling (e.g., videos shown in a health care provider's office) and broadcast advertisements, since the taxonomy has no separate audiovisual value.
Check
Do not flag the absence of a spoken established name in the audio track of audiovisual or broadcast pieces.
Where this comes from
Section II.D.2 · page 8. The highlighted words are quoted exactly; a script confirms they appear in the source before the rule can be published.
…proprietary name in the audiovisual promotional labeling or broadcast advertisement. When the established name accompanies the proprietary name, FDA recommends that the established name be displayed on the screen for the same amount of time as the proprietary name. For superimposed text that typically appears along the bottom of the screen, the established name does not have to be included with the proprietary name. FDA does not intend to object if the established name is not included in the audio portion of audiovisual promotional labeling or in an audiovisual broadcast advertisement. For radio and telephone advertisements, FDA does not intend to object if the established name is disclosed in direct conjunction with the most prominent presentation of the proprietary name. Under most circumstances, this is the first occurrence in the broadcast. Contains Nonbinding Recommendations 3. Electronic and Computer-Based Promotion Promotion in electronic and computer-based media…
- Document
- FDA guidance: Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling (final)
- Version
- as retrieved — the publisher does not version this document; the fingerprint below identifies the exact file
- Retrieved
- 2026-09-21 from www.fda.gov
- Fingerprint
- f6f78606542ef91596ef21f6…
FDA guidance describes the agency's current thinking. It is not binding law, and this rule is a recommendation, not an obligation.